Toward More Tailored Dosing Strategies While the panacea of individualised dosing regimens might represent a leap too far in terms of complexity, the opportunity does exist for pharmaceutical companies to implement a more tailored approach when it comes to dosing, arriving at a more delicate balance of drug exposure, bioavailability, efficacy and safety based on the characteristics of certain patient cohorts
Wegovy is approved for people 12 and older
This meta-analysis evaluates their effects on mortality and hospitalization in HFpEF
Naur P, Hansen KB, Kristensen AS, Dravid SM, Pickering DS, Olsen L, et al
Proteins were detected using horseradish peroxidase (HRP)-conjugated IgG secondary antibody (#7074, Cell Signaling and 62-6520, Thermo Fisher Scientific) and SignalFire ECL Reagent (Cell Signaling)